Healthcare Economic Evaluation of Chronic Pain: Measuring the Economic, Social and Personal Impact of Chronic Pain and its Management

  • Rebecca L. Robinson
  • Thomas R. Vetter


The aim of this chapter is to provide an overview of the social and personal costs of chronic pain and the role of healthcare economic evaluation methods within the context of chronic pain management, using a standardized and scientific approach. An economic evaluation is essentially the comparative analysis of alternative courses of action in terms of both their costs and consequences (Drummond, Sculpher, Torrance, O’Brien, & Stoddart, 2005). Thus the fundamental tasks of any economic evaluation—including those concerned with heath services—are to identify, measure, value, and compare the costs and consequences of the alternatives being considered (Drummond, Sculpher et al., 2005). The types of healthcare economic evaluations, the categories of cost incorporated in healthcare economic evaluations, the possible perspectives of a healthcare economic evaluation, and a framework for assessing healthcare economic evaluations will first be discussed. The application of such...


Chronic Pain Economic Evaluation Chronic Fatigue Syndrome Incremental Cost Effectiveness Ratio Fibromyalgia Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abeles, A. M., Pillinger, M. H., Solitar, B. M., & Abeles, M. (2007). Narrative review: The pathophysiology of fibromyalgia. Annals of Internal Medicine, 146(10), 726–734.PubMedGoogle Scholar
  2. Adam, T., Koopmanschap, M. A., & Evans, D. B. (2003). Cost-effectiveness analysis: can we reduce variability in costing methods? International Journal of Technology Assessment in Health Care, 19(2), 407–420.PubMedCrossRefGoogle Scholar
  3. Affleck, G., Urrows, S., Tennen, H., Higgins, P., & Abeles, M. (1996). Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain, 68(2–3), 363–368.PubMedCrossRefGoogle Scholar
  4. Al-Allaf, A. W. (2007). Work disability and health system utilization in patients with fibromyalgia syndrome. Journal of Clinical Rheumatology: Practical Reports On Rheumatic & Musculoskeletal Diseases, 13(4), 199–201.Google Scholar
  5. American Pain Society. (2007). APS glossary of pain terminology. Retrieved November 1, 2007, from
  6. Anderson, J. J., Ruwe, M., Miller, D. R., Kazis, L., Felson, D. T., & Prashker, M. (2002). Relative costs and effectiveness of specialist and general internist ambulatory care for patients with 2 chronic musculoskeletal conditions. Journal of Rheumatology, 29(7), 1488–1495.PubMedGoogle Scholar
  7. Arnold, L. M. (2006). Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Research & Therapy, 8(4), 212.CrossRefGoogle Scholar
  8. Arts, M. P., Peul, W. C., Brand, R., Koes, B. W., & Thomeer, R. T. (2006). Cost-effectiveness of microendoscopic discectomy versus conventional open discectomy in the treatment of lumbar disc herniation: A prospective randomised controlled trial. BMC Musculoskeletal Disorders, 7, 42.PubMedCrossRefGoogle Scholar
  9. Asbring, P., & Narvanen, A. L. (2002). Women's experiences of stigma in relation to chronic fatigue syndrome and fibromyalgia. Qualitative Health Research, 12(2), 148–160.PubMedGoogle Scholar
  10. Atkinson, J. H., Slater, M. A., Patterson, T. L., Grant, I., & Garfin, S. R. (1991). Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: A controlled study. Pain, 45(2), 111–121.PubMedCrossRefGoogle Scholar
  11. Barber, J. A., & Thompson, S. G. (1998). Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ, 317(7167), 1195–1200.PubMedGoogle Scholar
  12. Behrens, V., Seligman, P., Cameron, L., Mathias, C. G., & Fine, L. (1994). The prevalence of back pain, hand discomfort, and dermatitis in the US working population. American Journal of Public Health, 84(11), 1780–1785.PubMedCrossRefGoogle Scholar
  13. Bennett, R., & Nelson, D. (2006). Cognitive behavioral therapy for fibromyalgia. Nature Clinical Practice Rheumatology, 2(8), 416–424.PubMedCrossRefGoogle Scholar
  14. Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007). An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord, 8, 27.PubMedCrossRefGoogle Scholar
  15. Berger, A., Dukes, E., Martin, S., Edelsberg, J., & Oster, G. (2007). Characteristics and healthcare costs of patients with fibromyalgia syndrome. International Journal of Clinical Practice, 61(9), 1498–1508.PubMedCrossRefGoogle Scholar
  16. Bernard, A. L., Prince, A., & Edsall, P. (2000). Quality of life issues for fibromyalgia patients. Arthritis Care and Research, 13(1), 42–50.PubMedCrossRefGoogle Scholar
  17. Biyani, A., & Andersson, G. B. (2004). Low back pain: Pathophysiology and management. Journal of the American Academy of Orthopaedic Surgeons, 12(2), 106–115.PubMedGoogle Scholar
  18. Blyth, F. M., March, L. M., Brnabic, A. J., & Cousins, M. J. (2004). Chronic pain and frequent use of health care. Pain, 111(1–2), 51–58.PubMedCrossRefGoogle Scholar
  19. Blyth, F. M., March, L. M., Brnabic, A. J., Jorm, L. R., Williamson, M., & Cousins, M. J. (2001). Chronic pain in Australia: A prevalence study. Pain, 89(2–3), 127–134.PubMedCrossRefGoogle Scholar
  20. Bombardier, C., & Eisenberg, J. (1985). Looking into the crystal ball: Can we estimate the lifetime cost of rheumatoid arthritis? Journal of Rheumatology, 12(2), 201–204.PubMedGoogle Scholar
  21. Bombardier, C., & Maetzel, A. (1999). Pharmacoeconomic evaluation of new treatments: Efficacy versus effectiveness studies? Annals of the Rheumatic Diseases, 58 Suppl 1, I82–I85.PubMedCrossRefGoogle Scholar
  22. Boonen, A., van den Heuvel, R., van Tubergen, A., Goossens, M., Severens, J. L., & van der Heijde, D. et al. (2005). Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Annals of the Rheumatic Diseases, 64(3), 396–402.PubMedCrossRefGoogle Scholar
  23. Brandenburg, N., Mucha, L., & Silverman, S. (2007). (939): Impact of fibromyalgia on medical care expenditures and productivity losses. The Journal of Pain, 8(4, Supplement 1), S85.CrossRefGoogle Scholar
  24. Briggs, A. (2000). Handling uncertainty in cost-effectiveness models. Pharmacoeconomics, 17(5), 479–500.PubMedCrossRefGoogle Scholar
  25. Briggs, A. (2001). Handling uncertainty in economic evaluation and presenting results. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care: Merging theory with practice (pp. 172–214). New York: Oxford University Press.Google Scholar
  26. Briggs, A., & Gray, A. (1998). Power and sample size calculations for stochastic cost-effectiveness analysis. Medical Decision Making, 18(2 Suppl), S81–S92.PubMedCrossRefGoogle Scholar
  27. Briggs, A., & Gray, A. (1999). Handling uncertainty in economic evaluations of healthcare interventions. BMJ, 319(7210), 635–638.PubMedGoogle Scholar
  28. Briggs, A., Mooney, C., & Wonderling, D. (1999). Constructing confidence intervals for cost-effectiveness ratios: An evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Statistics in Medicine, 18(23), 3245–3262.PubMedCrossRefGoogle Scholar
  29. Briggs, A., O'Brien, B., & Blackhouse, G. (2002). Thinking outside the box: Recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health, 23, 377–401.PubMedCrossRefGoogle Scholar
  30. Briggs, A., Sculpher, M., & Buxton, M. (1994). Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis. Health Economics, 3(2), 95–104.PubMedCrossRefGoogle Scholar
  31. Briggs, A., Wonderling, D., & Mooney, C. (1997). Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics, 6(4), 327–340.PubMedCrossRefGoogle Scholar
  32. Brouwer, W., Rutten, F., & Koopmanschap, M. A. (2001). Costing in economic evaluation. In M. Drummond & A. McGuire (Eds.), Economic evaluation in health care: Merging theory with practice (pp. 68–93). New York: Oxford University Press.Google Scholar
  33. Brown, G. C., Brown, M. M., & Sharma, S. (2005). Evidence-based to value-based medicine. Chicago: AMA Press.Google Scholar
  34. Burckhardt, C. S. (2006). Multidisciplinary approaches for management of fibromyalgia. Current Pharmaceutical Design, 12(1), 59–66.PubMedCrossRefGoogle Scholar
  35. Carey, T. S., Evans, A., Hadler, N., Kalsbeek, W., McLaughlin, C., & Fryer, J. (1995). Care-seeking among individuals with chronic low back pain. Spine, 20(3), 312–317.PubMedCrossRefGoogle Scholar
  36. Carragee, E. J. (2005). Clinical practice. Persistent low back pain. The New England Journal of Medicine, 352(18), 1891–1898.PubMedCrossRefGoogle Scholar
  37. Cathey, M. A., Wolfe, F., & Kleinheksel, S. M. (1988). Functional ability and work status in patients with fibromyalgia. Arthritis Care and Research, 1(2), 85–98.CrossRefGoogle Scholar
  38. Centers for Disease Control and Prevention. (2005). Chronic disease overview. Retrieved November 1, 2007, from
  39. Chakrabarty, S., & Zoorob, R. (2007). Fibromyalgia. American Family Physician, 76(2), 247–254.PubMedGoogle Scholar
  40. Cherkin, D. C., Wheeler, K. J., Barlow, W., & Deyo, R. A. (1998). Medication use for low back pain in primary care. Spine, 23(5), 607–614.PubMedCrossRefGoogle Scholar
  41. Chou, R. (2005). Evidence-based medicine and the challenge of low back pain: where are we now? Pain Practice: The Official Journal of World Institute Of Pain, 5(3), 153–178.Google Scholar
  42. Cook, J. R., Drummond, M., Glick, H., & Heyse, J. F. (2003). Assessing the appropriateness of combining economic data from multinational clinical trials. Statistics in Medicine, 22(12), 1955–1976.PubMedCrossRefGoogle Scholar
  43. Critchley, D. J., Ratcliffe, J., Noonan, S., Jones, R. H., & Hurley, M. V. (2007). Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: A pragmatic randomized trial with economic evaluation. Spine, 32(14), 1474–1481.PubMedCrossRefGoogle Scholar
  44. Cudney, S. A., Butler, M. R., Weinert, C., & Sullivan, T. (2002). Ten rural women living with fibromyalgia tell it like it is. Holistic Nursing Practice, 16(3), 35–45.PubMedGoogle Scholar
  45. de Girolamo, G. (1991). Epidemiology and social costs of low back pain and fibromyalgia. The Clinical Journal of Pain, 7 Suppl 1, S1–S7.PubMedGoogle Scholar
  46. de Lissovoy, G., Brown, R. E., Halpern, M., Hassenbusch, S. J., & Ross, E. (1997). Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome. Clinical Therapeutics, 19(1), 96–112.PubMedCrossRefGoogle Scholar
  47. Detsky, A. S. (1995). Evidence of effectiveness: evaluating its quality. In F. A. Sloan (Ed.), Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies (pp. 15–29). Cambridge, UK: Cambridge University Press.CrossRefGoogle Scholar
  48. Detsky, A. S., & Naglie, I. G. (1990). A clinician's guide to cost-effectiveness analysis. Annals of Internal Medicine, 113(2), 147–154.PubMedGoogle Scholar
  49. Drummond, M. (2001). Introducing economic and quality of life measurements into clinical studies. Annals of Medicine, 33(5), 344–349.PubMedCrossRefGoogle Scholar
  50. Drummond, M., Bloom, B. S., Carrin, G., Hillman, A. L., Hutchings, H. C., & Knill-Jones, et al. (1992). Issues in the cross-national assessment of health technology. International Journal of Technology Assessment in Health Care, 8(4), 671–682.PubMedCrossRefGoogle Scholar
  51. Drummond, M., Manca, A., & Sculpher, M. (2005). Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies. International Journal of Technology Assessment in Health Care, 21(2), 165–171.PubMedGoogle Scholar
  52. Drummond, M., & Pang, F. (2001). Transferability of economic evaluation results In A. McGuire & M. Drummond (Eds.), Economic evaluation in health care: Merging theory with practice (pp. 256–276). Oxford: Oxford University Press.Google Scholar
  53. Drummond, M., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for economic evaluation of health care programmes (3rd ed.). New York: Oxford University Press.Google Scholar
  54. Duckro, P. N., Schultz, K. T., & Chibnall, J. T. (1994). Migraine as a sequela to chronic low back pain. Headache, 34(5), 279–281.PubMedCrossRefGoogle Scholar
  55. Ekman, M., Jonhagen, S., Hunsche, E., & Jonsson, L. (2005). Burden of illness of chronic low back pain in Sweden: A cross-sectional, retrospective study in primary care setting. Spine, 30(15), 1777–1785.PubMedCrossRefGoogle Scholar
  56. Engel, C. C., von Korff, M., & Katon, W. J. (1996). Back pain in primary care: predictors of high health-care costs. Pain, 65(2–3), 197–204.PubMedCrossRefGoogle Scholar
  57. Feeny, D. H. (2005). Preference-based utility measures: utility and quality-adjusted life years. In P. Fayers & R. Hays (Eds.), Assessing quality of life in clinical trials (2nd ed., pp. 406–429). New York: Oxford University Press.Google Scholar
  58. Fishbain, D. A., Cutler, R. B., Cole, B., Lewis, J., Smets, E., & Rosomoff, H. L., et al. (2004). Are patients with chronic low back pain or chronic neck pain fatigued? Pain Medicine (Malden, Mass.), 5(2), 187–195.CrossRefGoogle Scholar
  59. Fleming, S., Rabago, D. P., Mundt, M. P., & Fleming, M. F. (2007). CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complementary and Alternative Medicine, 7, 15.PubMedCrossRefGoogle Scholar
  60. Fritzell, P., Hagg, O., Jonsson, D., & Nordwall, A. (2004). Cost-effectiveness of lumbar fusion and nonsurgical treatment for chronic low back pain in the Swedish Lumbar Spine Study: A multicenter, randomized, controlled trial from the Swedish Lumbar Spine Study Group. Spine, 29(4), 421–434.PubMedCrossRefGoogle Scholar
  61. Frymoyer, J. W., & Cats-Baril, W. L. (1991). An overview of the incidences and costs of low back pain. Orthopedic Clinics of North America, 22(2), 263–271.PubMedGoogle Scholar
  62. Furlan, A. D., Sandoval, J. A., Mailis-Gagnon, A., & Tunks, E. (2006). Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ, 174(11), 1589–1594.PubMedGoogle Scholar
  63. Garcia, J., Simon, M. A., Duran, M., Canceller, J., & Aneiros, F. J. (2006). Differential efficacy of a cognitive-behavioral intervention versus pharmacological treatment in the management of fibromyalgic syndrome. Psychology, Health & Medicine, 11(4), 498–506.CrossRefGoogle Scholar
  64. Gilbert, F. J., Grant, A. M., Gillan, M. G. C., Vale, L. D., Campbell, M. K., & Scott, N. W., et al. (2004). Low back pain: Influence of early MR imaging or CT on treatment and outcome – Multicenter randomized trial. Radiology, 231(2), 343–351.PubMedCrossRefGoogle Scholar
  65. Glick, H. A., Doshi, J., Sonnad, S., & Polsky, D. (2007). Economic evaluation in clinical trials. New York: Oxford University Press.Google Scholar
  66. Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. (2003). The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. Journal of Occupational and Environmental Medicine, 45(1), 5–14.PubMedCrossRefGoogle Scholar
  67. Goldenberg, D. L. (2007). Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Practice & Research. Clinical Rheumatology, 21(3), 499–511.CrossRefGoogle Scholar
  68. Goldenberg, D. L., Burckhardt, C., & Crofford, L. (2004). Management of fibromyalgia syndrome. JAMA, 292(19), 2388–2395.PubMedCrossRefGoogle Scholar
  69. Goossens, M. E., Evers, S. M., Vlaeyen, J. W., Rutten-van Molken, M. P., & van der Linden, S. M. (1999). Principles of economic evaluation for interventions of chronic musculoskeletal pain. European Journal of Pain, 3(4), 343–353.PubMedCrossRefGoogle Scholar
  70. Goossens, M. E., Rutten-van Molken, M. P., Leidl, R. M., Bos, S. G., Vlaeyen, J. W., & Teeken-Gruben, N. J. (1996). Cognitive-educational treatment of fibromyalgia: A randomized clinical trial. II. Economic evaluation. Journal of Rheumatology, 23(7), 1246–1254.PubMedGoogle Scholar
  71. Grabois, M. (2005). Management of chronic low back pain. American Journal of Physical Medicine and Rehabilitation, 84(3 Suppl), S29–41.PubMedGoogle Scholar
  72. Grimes, D. A., & Schulz, K. F. (2002). An overview of clinical research: The lay of the land. Lancet, 359(9300), 57–61.PubMedCrossRefGoogle Scholar
  73. Guo, H. R., Tanaka, S., Cameron, L. L., Seligman, P. J., Behrens, V. J., & Ger, J., et al. (1995). Back pain among workers in the United States: National estimates and workers at high risk. American Journal of Industrial Medicine, 28(5), 591–602.PubMedCrossRefGoogle Scholar
  74. Hadler, N. M., Tait, R. C., & Chibnall, J. T. (2007). Back pain in the workplace. JAMA, 297(14), 1594–1596.PubMedCrossRefGoogle Scholar
  75. Halliday, R. G., & Darba, J. (2003). Cost data assessment in multinational economic evaluations: some theory and review of published studies. Applied Health Economics and Health Policy, 2(3), 149–155.PubMedGoogle Scholar
  76. Hart, L. G., Deyo, R. A., & Cherkin, D. C. (1995). Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine, 20(1), 11–19.PubMedCrossRefGoogle Scholar
  77. Hazard, R. G. (2007). Low-back and neck pain diagnosis and treatment. American Journal of Physical Medicine and Rehabilitation, 86(1 Suppl), S59–S68.PubMedCrossRefGoogle Scholar
  78. Hoffman, P. K., Meier, B. P., & Council, J. R. (2002). A comparison of chronic pain between an urban and rural population. Journal of Community Health Nursing, 19(4), 213–224.PubMedGoogle Scholar
  79. Hughes, G., Martinez, C., Myon, E., Taeb, C., & Wessely, S. (2006). The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: An observational study based on clinical practice. Arthritis and Rheumatism, 54(1), 177–183.PubMedCrossRefGoogle Scholar
  80. Indahl, A. (2004). Low back pain: Diagnosis, treatment, and prognosis. Scandinavian Journal of Rheumatology, 33(4), 199–209.PubMedCrossRefGoogle Scholar
  81. James Cook University. (2004). Economic burden of back pain tops $9 billion [Electronic Version]. Outlook, 16, 12–13. Retrieved November 6, 2007 from
  82. Jefferson, T., Demicheli, V., & Mugford, M. (2000). Elementary economic evaluation in health care (2nd ed.). London: BMJ Publishing Group.Google Scholar
  83. Jones, K. D., Adams, D., Winters-Stone, K., & Burckhardt, C. S. (2006). A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988–2005). Health and Quality of Life Outcomes, 4, 67.PubMedCrossRefGoogle Scholar
  84. Kocher, M. S., & Henley, M. B. (2003). It is money that matters: Decision analysis and cost-effectiveness analysis. Clinical Orthopedics and Related Research(413), 106–116.Google Scholar
  85. Koes, B. W., van Tulder, M. W., Ostelo, R., Burton, A. K., & Waddell, G. (2001). Clinical guidelines for the management of low back pain in primary care: An international comparison. Spine, 26(22), 2504–2513.PubMedCrossRefGoogle Scholar
  86. Koopmanschap, M. A., Rutten, F. F., van Ineveld, B. M., & van Roijen, L. (1995). The friction cost method for measuring indirect costs of disease. Journal of Health Economics, 14(2), 171–189.PubMedCrossRefGoogle Scholar
  87. Koopmanschap, M. A., Touw, K. C. R., & Rutten, F. F. H. (2001). Analysis of costs and cost-effectiveness in multinational trials. Health Policy, 58(2), 175–186.PubMedCrossRefGoogle Scholar
  88. Korthals-de Bos, I., van Tulder, M., van Dieten, H., & Bouter, L. (2004). Economic evaluations and randomized trials in spinal disorders: Principles and methods. Spine, 29(4), 442–448.CrossRefGoogle Scholar
  89. Kovacs, F. M., Fernandez, C., Cordero, A., Muriel, A., Gonzalez-Lujan, L., & Gil del Real, M. T. (2006). Non-specific low back pain in primary care in the Spanish National Health Service: A prospective study on clinical outcomes and determinants of management. BMC Health Services Research, 6, 57.PubMedCrossRefGoogle Scholar
  90. Kovacs, F. M., Llobera, J., Abraira, V., Lazaro, P., Pozo, F., & Kleinbaum, D. (2002). Effectiveness and cost-effectiveness analysis of neuroreflexotherapy for subacute and chronic low back pain in routine general practice: A cluster randomized, controlled trial. Spine, 27(11), 1149–1159.PubMedCrossRefGoogle Scholar
  91. Lind, B. K., Lafferty, W. E., Tyree, P. T., Diehr, P. K., & Grembowski, D. E. (2007). Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis and Rheumatism, 57(1), 71–76.PubMedCrossRefGoogle Scholar
  92. Loisel, P., Lemaire, J., Poitras, S., Durand, M. J., Champagne, F., & Stock, S., et al. (2002). Cost-benefit and cost-effectiveness analysis of a disability prevention model for back pain management: A six year follow up study. Occupational and Environmental Medicine, 59(12), 807–815.PubMedCrossRefGoogle Scholar
  93. Loney, P. L., & Stratford, P. W. (1999). The prevalence of low back pain in adults: a methodological review of the literature. Physical Therapy, 79(4), 384–396.PubMedGoogle Scholar
  94. Luce, B. R., Manning, W. G., Siegel, J. E., & Lipscomb, J. (1996). Estimating costs in cost-effectiveness analysis. In M. R. Gold, J. E. Siegel, L. B. Russell, & M. C. Weinstein (Eds.), Cost-effectiveness in health and medicine (pp. 176–213). New York: Oxford University Press.Google Scholar
  95. Luo, X., Pietrobon, R., Sun, S. X., Liu, G. G., & Hey, L. (2004). Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine, 29(1), 79–86.PubMedCrossRefGoogle Scholar
  96. Maetzel, A., & Li, L. (2002). The economic burden of low back pain: A review of studies published between 1996 and 2001. Best Practice & Research. Clinical Rheumatology, 16(1), 23–30.CrossRefGoogle Scholar
  97. Malter, A. D., Larson, E. B., Urban, N., & Deyo, R. A. (1996). Cost-effectiveness of lumbar discectomy for the treatment of herniated intervertebral disc. Spine, 21(9), 1048–1054.PubMedCrossRefGoogle Scholar
  98. Manca, A., Dumville, J. C., Torgerson, D. J., Klaber Moffett, J. A., Mooney, M. P., & Jackson, D. A., et al. (2007). Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: Cost effectiveness analysis. Rheumatology, 46(9), 1495–1501.PubMedCrossRefGoogle Scholar
  99. Mäntyselkä, P., Kumpusalo, E., Ahonen, R., Kumpusalo, A., Kauhanen, J., & Viinamaki, H., et al. (2001). Pain as a reason to visit the doctor: A study in Finnish primary health care. Pain, 89(2–3), 175–180.PubMedCrossRefGoogle Scholar
  100. Mäntyselkä, P., Turunen, J. H., Ahonen, R. S., & Kumpusalo, E. A. (2003). Chronic pain and poor self-rated health. JAMA, 290(18), 2435–2442.PubMedCrossRefGoogle Scholar
  101. Martinez, J. E., Ferraz, M. B., Sato, E. I., & Atra, E. (1995). Fibromyalgia versus rheumatoid arthritis: A longitudinal comparison of the quality of life. Journal of Rheumatology, 22(2), 270–274.PubMedGoogle Scholar
  102. McCarberg, B. H., & Billington, R. (2006). Consequences of neuropathic pain: quality-of-life issues and associated costs. American Journal of Managed Care, 12(9 Suppl), S263–S268.PubMedGoogle Scholar
  103. Mease, P. (2005). Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. The Journal of Rheumatology. Supplement, 75, 6–21.PubMedGoogle Scholar
  104. Miller, P., Kendrick, D., Bentley, E., & Fielding, K. (2002). Cost-effectiveness of lumbar spine radiography in primary care patients with low back pain. Spine, 27(20), 2291–2297.PubMedCrossRefGoogle Scholar
  105. Morris, C. R., Bowen, L., & Morris, A. J. (2005). Integrative therapy for fibromyalgia: Possible strategies for an individualized treatment program. Southern Medical Journal, 98(2), 177–184.PubMedCrossRefGoogle Scholar
  106. Muennig, P. (2002). Designing and conducting cost-effectiveness analyses in medicine and health care. San Francisco: Jossey-Bass.Google Scholar
  107. Mullahy, J., & Manning, W. (1994). Statistical issues in cost-effectiveness analysis. In F. A. Sloan (Ed.), Valuing health care (pp. 149–184). Cambridge, UK: Cambridge University Press.Google Scholar
  108. Myriam Hunink, M. G., Glasziou, P. P., Siegel, J. E., Weeks, J. C., Pliskin, J. S., & Elstein, A. S., et al. (2001). Decision making in health and medicine: Integrating evidence and values. Cambridge, UK: Cambridge University Press.Google Scholar
  109. National Institute of Neurological Disorders and Stroke. (2007). Low back pain fact sheet. Retrieved November 1, 2007, from
  110. Neumann, P. J. (2005). Using cost-effectiveness analysis to improve health care: Opportunities and barriers. New York: Oxford University Press.Google Scholar
  111. Newton, W., Curtis, P., Witt, P., & Hobler, K. (1997). Prevalence of subtypes of low back pain in a defined population. Journal of Family Practice, 45(4), 331–335.PubMedGoogle Scholar
  112. Niemisto, L., Rissanen, P., Sarna, S., Lahtinen-Suopanki, T., Lindgren, K. A., & Hurri, H. (2005). Cost-effectiveness of combined manipulation, stabilizing exercises, and physician consultation compared to physician consultation alone for chronic low back pain: A prospective randomized trial with 2-year follow-up. Spine, 30(10), 1109–1115.PubMedCrossRefGoogle Scholar
  113. Nord, E. (1999). Cost-value in health care: Making sense out of QALYs. New York: Cambridge University Press.Google Scholar
  114. North, R. B., Kidd, D., Shipley, J., & Taylor, R. S. (2007). Spinal cord stimulation versus reoperation for failed back surgery syndrome: A cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery, 61(2), 361–368.PubMedCrossRefGoogle Scholar
  115. O'Brien, B. (1996). Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? Medical Care, 34(12 Suppl), DS99–108.PubMedGoogle Scholar
  116. O'Brien, B. (1997). A tale of two (or more) cities: Geographic transferability of pharmacoeconomic data. American Journal of Managed Care, 3 Suppl, S33–S39.PubMedGoogle Scholar
  117. O'Brien, B., & Briggs, A. (2002). Analysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methods. Statistical Methods in Medical Research, 11(6), 455–468.PubMedCrossRefGoogle Scholar
  118. O'Brien, B., Drummond, M. F., Labelle, R. J., & Willan, A. (1994). In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care, 32(2), 150–163.PubMedCrossRefGoogle Scholar
  119. Obenchain, R. L., Robinson, R. L., & Swindle, R. W. (2005). Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance. Journal of Biopharmaceutical Statistics, 15(3), 419–436.PubMedCrossRefGoogle Scholar
  120. Olsen, J. A., & Smith, R. D. (2001). Theory versus practice: a review of 'willingness-to-pay' in health and health care. Health Economics, 10(1), 39–52.PubMedCrossRefGoogle Scholar
  121. Oostenbrink, J. B., Koopmanschap, M. A., & Rutten, F. F. (2002). Standardisation of costs: The Dutch Manual for Costing in economic evaluations. Pharmacoeconomics, 20(7), 443–454.PubMedCrossRefGoogle Scholar
  122. Owens, D. K. (1998). Spine update. Patient preferences and the development of practice guidelines. Spine, 23(9), 1073–1079.PubMedCrossRefGoogle Scholar
  123. Pang, F. (2002). Design, analysis and presentation of mresentation of multinational economic studies – The need for guidance. Pharmacoeconomics, 20(2), 75–90.PubMedCrossRefGoogle Scholar
  124. Patrick, D. L., Deyo, R. A., Atlas, S. J., Singer, D. E., Chapin, A., & Keller, R. B. (1995). Assessing health-related quality of life in patients with sciatica. Spine, 20(17), 1899.PubMedCrossRefGoogle Scholar
  125. Penrod, J. R., Bernatsky, S., Adam, V., Baron, M., Dayan, N., & Dobkin, P. L. (2004). Health services costs and their determinants in women with fibromyalgia. Journal of Rheumatology, 31(7), 1391–1398.PubMedGoogle Scholar
  126. Perquin, C. W., Hazebroek-Kampschreur, A. A., Hunfeld, J. A., Bohnen, A. M., van Suijlekom-Smit, L. W., & Passchier, J., et al. (2000). Pain in children and adolescents: A common experience. Pain, 87(1), 51–58.PubMedCrossRefGoogle Scholar
  127. Phillips, C. J. (2003). Pain management: Health economics and quality of life considerations. Drugs, 63 Spec No 2, 47–50.PubMedCrossRefGoogle Scholar
  128. Phillips, K., Ch'ien, A. P. Y., Norwood, B. R., & Smith, C. (2003). Chronic low back pain management in primary care. The Nurse Practitioner, 28(8), 26–31.PubMedCrossRefGoogle Scholar
  129. Polatin, P. B., Kinney, R. K., Gatchel, R. J., Lillo, E., & Mayer, T. G. (1993). Psychiatric illness and chronic low-back pain. The mind and the spine–which goes first? Spine, 18(1), 66–71.PubMedCrossRefGoogle Scholar
  130. Polsky, D., Glick, H. A., Willke, R., & Schulman, K. (1997). Confidence intervals for cost-effectiveness ratios: A comparison of four methods. Health Economics, 6(3), 243–252.PubMedCrossRefGoogle Scholar
  131. Price, C., Arden, N., Coglan, L., & Rogers, P. (2005). Cost-effectiveness and safety of epidural steroids in the management of sciatica. Health Technology Assessment, 9(33), 1–58.PubMedGoogle Scholar
  132. Ramsey, S., McIntosh, M., & Sullivan, S. (2001). Design issues for conducting cost-effectiveness analyses alongside clinical trials. Annual Review of Public Health, 22, 129–141.PubMedCrossRefGoogle Scholar
  133. Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., & Chawla, A., et al. (2005). Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health, 8(5), 521–533.PubMedCrossRefGoogle Scholar
  134. Raphael, K. G., Janal, M. N., Nayak, S., Schwartz, J. E., & Gallagher, R. M. (2006). Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain, 124(1–2), 117–125.PubMedCrossRefGoogle Scholar
  135. Ratcliffe, J., Thomas, K. J., MacPherson, H., & Brazier, J. (2006). A randomised controlled trial of acupuncture care for persistent low back pain: Cost effectiveness analysis. BMJ, 333(7569), 626.PubMedCrossRefGoogle Scholar
  136. Reed, S. D., Anstrom, K. J., Bakhai, A., Briggs, A. H., Califf, R. M., & Cohen, D. J., et al. (2005). Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus. American Heart Journal, 149(3), 434–443.PubMedCrossRefGoogle Scholar
  137. Reisine, S., Fifield, J., Walsh, S. J., & Feinn, R. (2003). Do employment and family work affect the health status of women with fibromyalgia? Journal of Rheumatology, 30(9), 2045–2053.PubMedGoogle Scholar
  138. Rivero-Arias, O., Campbell, H., Gray, A., Fairbank, J., Frost, H., & Wilson-MacDonald, J. (2005). Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: Cost utility analysis based on a randomised controlled trial. BMJ, 330(7502), 1239–1243.PubMedCrossRefGoogle Scholar
  139. Rivero-Arias, O., Gray, A., Frost, H., Lamb, S. E., & Stewart-Brown, S. (2006). Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain. Spine, 31(12), 1381–1387.PubMedCrossRefGoogle Scholar
  140. Rizzo, J. A., Abbott, T. A., 3rd, & Berger, M. L. (1998). The labor productivity effects of chronic backache in the United States. Medical Care, 36(10), 1471–1488.PubMedCrossRefGoogle Scholar
  141. Robinson, R. (1993a). Cost-benefit analysis. BMJ, 307(6909), 924–926.Google Scholar
  142. Robinson, R. (1993b). Cost-effectiveness analysis. BMJ, 307(6907), 793–795.Google Scholar
  143. Robinson, R. (1993c). Cost-utility analysis. BMJ, 307(6908), 859–862.Google Scholar
  144. Robinson, R. (1993d). Costs and cost-minimisation analysis. BMJ, 307(6906), 726–728.Google Scholar
  145. Robinson, R. L., Birnbaum, H. G., Morley, M. A., Sisitsky, T., Greenberg, P. E., & Claxton, A. J. (2003). Economic cost and epidemiological characteristics of patients with fibromyalgia claims. Journal of Rheumatology, 30(6), 1318–1325.PubMedGoogle Scholar
  146. Robinson, R. L., Birnbaum, H. G., Morley, M. A., Sisitsky, T., Greenberg, P. E., & Wolfe, F. (2004). Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. The Journal Of Rheumatology, 31(8), 1621–1629.PubMedGoogle Scholar
  147. Robinson, R. L., & Jones, M. L. (2006). In search of pharmacoeconomic evaluations for fibromyalgia treatments: A review. Expert Opinion on Pharmacotherapy, 7(8), 1027–1039.PubMedCrossRefGoogle Scholar
  148. Rooks, D. S. (2007). Fibromyalgia treatment update. Current Opinion in Rheumatology, 19(2), 111–117.PubMedGoogle Scholar
  149. Rubin, D. I. (2007). Epidemiology and risk factors for spine pain. Neurologic Clinics, 25(2), 353–371.PubMedCrossRefGoogle Scholar
  150. Russell, I. J. (2006). Fibromyalgia [Electronic Version]. Essential Science Indicators. Retrieved November 2, 2007 from
  151. Russell, L. B., Siegel, J. E., Daniels, N., Gold, M. R., Luce, B. R., & Mandelblatt, J. S. (1996). Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations. In M. R. Gold, J. E. Siegel, L. B. Russell, & M. C. Weinstein (Eds.), Cost-effectiveness in health and medicine (pp. 3–24). New York: Oxford University Press.Google Scholar
  152. Sculpher, M. J., Pang, F. S., Manca, A., Drummond, M. F., Golder, S., & Urdahl, H., et al. (2004). Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technology Assessment, 8(49), 1–192.Google Scholar
  153. Sherman, K. J., Cherkin, D. C., Connelly, M. T., Erro, J., Savetsky, J. B., & Davis, R. B., et al. (2004). Complementary and alternative medical therapies for chronic low back pain: What treatments are patients willing to try? BMC Complementary and Alternative Medicine, 4, 9.PubMedCrossRefGoogle Scholar
  154. Smith, A. F., & Brown, G. C. (2000). Understanding cost effectiveness: A detailed review. British Journal of Ophthalmology, 84(7), 794–798.PubMedCrossRefGoogle Scholar
  155. Staud, R. (2006). Biology and therapy of fibromyalgia: Pain in fibromyalgia syndrome. Arthritis Research & Therapy, 8(3), 208.CrossRefGoogle Scholar
  156. Staud, R. (2007). Treatment of fibromyalgia and its symptoms. Expert Opinion on Pharmacotherapy, 8(11), 1629–1642.PubMedCrossRefGoogle Scholar
  157. Steenstra, I. A., Anema, J. R., van Tulder, M. W., Bongers, P. M., de Vet, H. C., & van Mechelen, W. (2006). Economic evaluation of a multi-stage return to work program for workers on sick-leave due to low back pain. Journal of Occupational Rehabilitation, 16(4), 557–578.PubMedCrossRefGoogle Scholar
  158. Stewart, W. F., Ricci, J. A., Chee, E., Morganstein, D., & Lipton, R. (2003). Lost productive time and cost due to common pain conditions in the US Workforce. JAMA, 290(18), 2443–2454.PubMedCrossRefGoogle Scholar
  159. Stone, P. W., Chapman, R. H., Sandberg, E. A., Liljas, B., & Neumann, P. J. (2000). Measuring costs in cost-utility analyses. Variations in the literature. International Journal of Technology Assessment in Health Care, 16(1), 111–124.PubMedCrossRefGoogle Scholar
  160. Strom, B. L. (1994). Pharmacoepidemiology (2nd ed.). New York: John Wiley & Sons.Google Scholar
  161. Strong, L. L., Von Korff, M., Saunders, K., & Moore, J. E. (2006). Cost-effectiveness of two self-care interventions to reduce disability associated with back pain. Spine, 31(15), 1639–1645.PubMedCrossRefGoogle Scholar
  162. Sutherland, H. J., & Till, J. E. (1993). Quality of life assessments and levels of decision making: Differentiating objectives. Quality of Life Research, 2(4), 297–303.PubMedCrossRefGoogle Scholar
  163. Tait, R. C., Margolis, R. B., Krause, S. J., & Liebowitz, E. (1988). Compensation status and symptoms reported by patients with chronic pain. Archives of Physical Medicine and Rehabilitation, 69(12), 1027–1029.PubMedGoogle Scholar
  164. Taylor, R. J., & Taylor, R. S. (2005). Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. International Journal of Technology Assessment in Health Care, 21(3), 351–358.PubMedCrossRefGoogle Scholar
  165. Taylor, R. S., Taylor, R. J., Van Buyten, J. P., Buchser, E., North, R., & Bayliss, S. (2004). The cost effectiveness of spinal cord stimulation in the treatment of pain: A systematic review of the literature. Journal of Pain and Symptom Management, 27(4), 370–378.PubMedCrossRefGoogle Scholar
  166. Tella, M. N., Feinglass, J., & Chang, R. W. (2003). Cost-effectiveness, cost-utility, and cost-benefit studies in rheumatology: A review of the literature, 2001–2002. Current Opinion in Rheumatology, 15(2), 127–131.PubMedCrossRefGoogle Scholar
  167. Thieme, K., Flor, H., & Turk, D. C. (2006). Psychological pain treatment in fibromyalgia syndrome: Efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Research & Therapy, 8(4), R121.CrossRefGoogle Scholar
  168. Thompson, S. G., & Barber, J. A. (2000). How should cost data in pragmatic randomised trials be analysed? BMJ, 320(7243), 1197–1200.PubMedCrossRefGoogle Scholar
  169. Thomsen, A. B., Sorensen, J., Sjogren, P., & Eriksen, J. (2002). Chronic non-malignant pain patients and health economic consequences. European Journal of Pain, 6(5), 341–352.PubMedCrossRefGoogle Scholar
  170. Torrance, G. W. (1987). Measurement of health utilities for economic appraisals. Journal of Health Economics, 5, 1–30.CrossRefGoogle Scholar
  171. Torrance, G. W. (1997). Preferences for health outcomes and cost-utility analysis. American Journal of Managed Care, 3 Suppl, S8–S20.PubMedGoogle Scholar
  172. Torrance, G. W., Siegel, J. E., & Luce, B. R. (1996). Framing and designing the cost-effectiveness study. In M. R. Gold, J. E. Siegel, L. B. Russell, & M. C. Weinstein (Eds.), Cost-effectiveness in health and medicine (pp. 54–81). New York: Oxford University Press.Google Scholar
  173. Tosteson, A. N. (2000). Preference-based health outcome measures in low back pain. Spine, 25(24), 3161–3166.PubMedCrossRefGoogle Scholar
  174. Turk, D. C., & Okifuji, A. (1998). Treatment of chronic pain patients: Clinical outcomes, cost-effectiveness, and cost-benefits of multidisciplinary pain centers. Critical Reviews in Physical and Rehabilitation Medicine, 10(2), 181–208.Google Scholar
  175. Turk, D. C., & Okifuji, A. (2004). Psychological aspects of pain. In C. A. Warfield & Z. H. Bajwa (Eds.), Principles and practice of pain medicine (pp. 139–156). New York: McGraw-Hill.Google Scholar
  176. UK BEAM Trial Team. (2004). United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: Cost effectiveness of physical treatments for back pain in primary care. BMJ, 329(7479), 1381–1385.CrossRefGoogle Scholar
  177. van der Roer, N., Boos, N., & van Tulder, M. W. (2006). Economic evaluations: A new avenue of outcome assessment in spinal disorders. European Spine Journal, 15 Suppl 1, S109–S117.PubMedCrossRefGoogle Scholar
  178. van der Roer, N., Goossens, M. E., Evers, S. M., & van Tulder, M. W. (2005). What is the most cost-effective treatment for patients with low back pain? A systematic review. Best Practice & Research Clinical Rheumatology, 19(4), 671–684.CrossRefGoogle Scholar
  179. van der Roer, N., van Tulder, M. W., Barendse, J. M., van Mechelen, W., Franken, W. K., & Ooms, A. C., et al. (2004). Cost-effectiveness of an intensive group training protocol compared to physiotherapy guideline care for sub-acute and chronic low back pain: Design of a randomised controlled trial with an economic evaluation. BMC Musculoskeletal Disorders, 5, 45.PubMedCrossRefGoogle Scholar
  180. van Geen, J. W., Edelaar, M. J., Janssen, M., & van Eijk, J. T. (2007). The long-term effect of multidisciplinary back training: a systematic review. Spine, 32(2), 249–255.PubMedCrossRefGoogle Scholar
  181. van Koulil, S., Effting, M., Kraaimaat, F. W., van Lankveld, W., van Helmond, T., & Cats, H., et al. (2007). Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: State of the art and future directions. Annals of the Rheumatic Diseases, 66(5), 571–581.PubMedCrossRefGoogle Scholar
  182. Verhaak, P. F. M., Kerssens, J. J., Dekker, J., Sorbi, M. J., & Bensing, J. M. (1998). Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain, 77(3), 231–239.PubMedCrossRefGoogle Scholar
  183. Vetter, T. R. (2007a). The application of economic evaluation methods in the chronic pain medicine literature. Anesthesia and Analgesia, 105(1), 114–118.Google Scholar
  184. Vetter, T. R. (2007b). A primer on health-related quality of life in chronic pain medicine. Anesthesia and Analgesia, 104(3), 703–718.Google Scholar
  185. Vlaeyen, J. W., Teeken-Gruben, N. J., Goossens, M. E., Rutten-van Molken, M. P., Pelt, R. A., & van Eek, H., et al. (1996). Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. I. Clinical effects. Journal of Rheumatology, 23(7), 1237–1245.PubMedGoogle Scholar
  186. Vogt, M. T., Nevitt, M. C., & Cauley, J. A. (1997). Back problems and atherosclerosis. The Study of Osteoporotic Fractures. Spine, 22(23), 2741–2747.PubMedCrossRefGoogle Scholar
  187. Walen, H. R., Cronan, P. A., & Bigatti, S. M. (2001). Factors associated with healthcare costs in women with fibromyalgia. American Journal of Managed Care, 7 Spec No, SP39–S47.PubMedGoogle Scholar
  188. Waylonis, G. W., Ronan, P. G., & Gordon, C. (1994). A profile of fibromyalgia in occupational environments. American Journal of Physical Medicine and Rehabilitation, 73(2), 112–115.PubMedCrossRefGoogle Scholar
  189. Webster, B. S., & Snook, S. H. (1990). The cost of compensable low back pain. Journal of Occupational Medicine, 32(1), 13–15.PubMedCrossRefGoogle Scholar
  190. Weinstein, M. C., O'Brien, B., Hornberger, J., Jackson, J., Johannesson, M., & McCabe, C., et al. (2003). Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices–Modeling Studies. Value Health, 6(1), 9–17.PubMedCrossRefGoogle Scholar
  191. White, K., Nielson, W. R., Harth, M., Ostbye, T., & Speechley, M. (2002). Does the label “fibromyalgia” alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis and Rheumatism, 47(3), 260–265.PubMedCrossRefGoogle Scholar
  192. White, K., Speechley, M., Harth, M., & Ostbye, T. (1999a). Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis and Rheumatism, 42(1), 76–83.Google Scholar
  193. White, K., Speechley, M., Harth, M., & Ostbye, T. (1999b). The London Fibromyalgia Epidemiology Study: Comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. Journal of Rheumatology, 26(7), 1577–1585.Google Scholar
  194. White, K., Speechley, M., Harth, M., & Ostbye, T. (1999c). The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. Journal of Rheumatology, 26(4), 885–889.Google Scholar
  195. White, L. A., Birnbaum, H. G., Kaltenboeck, A., Tang, J., Mallet, D., & Robinson, R. L. (2008). Medical comorbidities, pharmaceutical use and health care costs in patients with fibromyalgia. Journal of Occupational and Environmental Medicine, 50, 13–24.Google Scholar
  196. Whitehurst, D. G., Lewis, M., Yao, G. L., Bryan, S., Raftery, J. P., & Mullis, R., et al. (2007). A brief pain management program compared with physical therapy for low back pain: Results from an economic analysis alongside a randomized clinical trial. Arthritis and Rheumatism, 57(3), 466–473.PubMedCrossRefGoogle Scholar
  197. Willke, R. J., Glick, H. A., Polsky, D., & Schulman, K. (1998). Estimating country-specific cost-effectiveness from multinational clinical trials. Health Economics, 7(6), 481–493.PubMedCrossRefGoogle Scholar
  198. Witt, C. M., Jena, S., Selim, D., Brinkhaus, B., Reinhold, T., & Wruck, K., et al. (2006). Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. American Journal of Epidemiology, 164(5), 487–496.PubMedCrossRefGoogle Scholar
  199. Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., & Goldenberg, D. L., et al. (1997a). A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis and Rheumatism, 40(9), 1560–1570.Google Scholar
  200. Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., & Goldenberg, D. L., et al. (1997b). Work and disability status of persons with fibromyalgia. Journal of Rheumatology, 24(6), 1171–1178.Google Scholar
  201. Wolfe, F., & Michaud, K. (2004). Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. Journal of Rheumatology, 31(4), 695–700.PubMedGoogle Scholar
  202. Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995). The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism, 38(1), 19–28.PubMedCrossRefGoogle Scholar
  203. Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., & Goldenberg, D. L., et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism, 33(2), 160–172.PubMedCrossRefGoogle Scholar
  204. Zagari, M. J., Mazonson, P. D., & Longton, W. C. (1996). Pharmacoeconomics of chronic nonmalignant pain. Pharmacoeconomics, 10(4), 356–377.PubMedCrossRefGoogle Scholar
  205. Zarnke, K. B., Levine, M. A., & O'Brien, B. J. (1997). Cost-benefit analyses in the health-care literature: don't judge a study by its label. Journal of Clinical Epidemiology, 50(7), 813–822.PubMedCrossRefGoogle Scholar
  206. Zijlstra, T. R., Braakman-Jansen, L. M., Taal, E., Rasker, J. J., & van de Laar, M. A. (2007). Cost-effectiveness of Spa treatment for fibromyalgia: General health improvement is not for free. Rheumatology, 46(9), 1454–1459.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Rebecca L. Robinson
    • 1
  • Thomas R. Vetter
  1. 1.Global Health Outcomes, Eli Lilly and CompanyIndianapolisUSA

Personalised recommendations